Patients with stable COPD have elevated serum levels of circulating pro-inflammatory mediators, such as C-reactive protein (CRP), fibrinogen, interleukin (IL)-6, and IL-8 [3], and there is an increase in T lymphocytes in the lung, predominantly CD8+ (cytotoxic) [4]. Here, CD8A is linked to chronic obstructive pulmonary disease.